Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes
Ferdinando Nicoletti(University of Catania), Ramón Gomis(Universitat de Barcelona), Roberto Di Marco(University of Catania), Klaus Bendtzen(Rigshospitalet), A Speciale(University of Catania), Rosa Morı́nigo(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Ignacio Conget(Universitat de Barcelona)
Cited by 92
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495